FDA Inspection 1120984 — LifeCell Corporation

LifeCell Corporation — FEI 1000306051

The FDA completed an inspection of LifeCell Corporation on Feb 20, 2020 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 20, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.